Biospace news

Syndicate content
RSS Feed for Biotech, Pharmaceutical and Clinical Research News | BioSpace (Generated by New Sloth)
URL: https://www.biospace.com/news/
Updated: 6 weeks 4 days ago

RSV Vaccine Makers Hit Hard by New CDC Guidelines

Fri, 08/02/2024 - 02:00
GSK, Moderna and Pfizer are all looking at potential respiratory syncytial virus vaccine sales slumps thanks to recently updated CDC guidelines regarding the use of RSV shots in seniors.

Adaptimmune’s Tecelra Becomes First FDA-Approved Engineered Cell Therapy for Solid Tumors

Fri, 08/02/2024 - 02:00

GSK Wins Broad Label Expansion for Jemperli in First-Line Endometrial Cancer

Fri, 08/02/2024 - 02:00

Vir Lays Off 25% of Staff, Abandons Most Virus Work and Pivots to Cancer in Sanofi Deal

Fri, 08/02/2024 - 02:00

Vertex Scraps Two Phase I AATD Candidates Following Disappointing Data

Fri, 08/02/2024 - 02:00

Biopharma Layoff Tracker 2024: uniQure, Vir, Arbutus and More Cut Staff

Fri, 08/02/2024 - 02:00

Moderna Cuts Full-Year Revenue Guidance as COVID-19 Vaccine Sales Crater in Q2

Thu, 08/01/2024 - 02:00

Otsuka Pays Up to $1.1B to Buy Jnana, Adds Drug Discovery Capabilities

Thu, 08/01/2024 - 02:00

Lilly’s Tirzepatide Clears Phase III Cardiovascular Study on Heels of Novo

Thu, 08/01/2024 - 02:00

FDA Questions Strength of Evidence Backing Zevra’s Rare Disease Therapy Ahead of Adcomm

Thu, 08/01/2024 - 02:00

Novo Loses IRA Case as NJ Judge Asserts Price Negotiations Are Voluntary

Thu, 08/01/2024 - 02:00

Sanofi Sues Sarepta Over Elevidys DMD Gene Therapy, Alleges Patent Infringement

Thu, 08/01/2024 - 02:00

5 Quick Ways to Strengthen Your LinkedIn Profile in 60 Minutes

Wed, 07/31/2024 - 02:00
Companies will look at job candidates’ LinkedIn profiles, so make sure yours is strong, from the summary of your expertise and qualifications to testimonials from colleagues.

Biopharma Investment Activity Continued to Rise in Q2: J.P. Morgan

Wed, 07/31/2024 - 02:00

New Leqembi Data Illuminate Longer-Term Effects, Tau Reduction

Wed, 07/31/2024 - 02:00

GSK Lowers Full-Year Vaccine Guidance After Disappointing Q2 Sales, CDC RSV Guidelines

Wed, 07/31/2024 - 02:00

Vertex Nabs Priority Review for Non-Opioid Pain Drug, Awaits January 2025 Decision

Wed, 07/31/2024 - 02:00

Incyte Trims Early-Stage Pipeline Amid Strategic Shift in R&D

Wed, 07/31/2024 - 02:00

Boehringer Buys Nerio Therapeutics for $1.3B to Boost Immuno-Oncology Pipeline

Mon, 07/29/2024 - 02:00
Under the deal announced Monday with the California biotech, German pharma Boehringer Ingelheim is gaining access to novel immune checkpoint inhibitors designed to activate the immune system to fight cancer cells.

WuXi AppTec Hit With Slight Drop in US Revenue as Threat of BIOSECURE Act Looms

Mon, 07/29/2024 - 02:00